Bollor CEO Rejects Ackmans Universal Bid as Insufficient Potential Deal Uncertainty Looms Hong Kong Airport Expansion May Accelerate Competition in Greater Bay Area Aviation Saregama India Shares Hold Steady Above Key Support Levels After Breakout EU and Mexico Sign Updated Trade Deal to Reduce Reliance on US and China Micron Technology Surges as UBS Triples Price Target on AI Demand Nears 1 Trillion Valuation European Officials See Extended Energy Price Pressures Through 2027 EDUC Q1 2026 Earnings Net Loss Reported as Company Navigates Transition Nokia Q1 2026 Earnings EPS Beats Estimates by 2285 as Cost Discipline Drives Profitability CBAN Q1 2026 Earnings Earnings Miss Weighs on Results Despite Modest Share Price Gain Imperial Petroleum Inc 875 Series A Cumulative Redeemable Perpetual Preferred Shares IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on 67 Beat PLMR Q1 2026 Earnings Earnings Beat Driven by Underwriting Strength DHCNI Q1 2026 Earnings EPS Miss Amid Challenging Operating Environment Knife Riv Holding Co KNF Posts Modest Gains Holds Above Key Support Level OReilly Automotive ORLY Slips Slightly Amid Mixed Market Sentiment Immersion Corporation IMMR Slips 132 as Stock Approaches Key Support Level Unum Group UNM Slips 095 as Stock Consolidates Near MidRange Eaton Vance Enhanced Equity Income Fund EOI Holds Near Key Resistance After Modest Gain Everyday Purchases as Teachable Moments How One MD Instills Financial Wisdom in Children Unum Group Q1 2026 Earnings Solid EPS Beat Amid Steady Performance FS KKR Capital Corp FSK Faces Continued Pressure Near Support After Modest Decline CME Q1 2026 Earnings EPS Slightly Misses Consensus as Shares Edge Higher Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Remitly Q1 2026 Earnings Stellar EPS Beat Fuels Optimism Revenue Details Remain Undisclosed JBG SMITH Properties JBGS Q1 2026 Earnings Modest Profit Amid Continued Portfolio Transition BRC Q1 2026 Earnings Strong EPS Beat Drives Stock Higher LCID Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline